Learn More
Medchemexpress LLC Ponatinib (hydrochloride) | 1114544-31-8 | 99.8% | 569.02 | 10 MG

Supplier: Medchemexpress LLC HY10876610MM/1ML
Ponatinib hydrochloride is a hydrochloride of ponatinib, an orally active multi-targeted kinase inhibitor. It targets Abl, PDGFRα, VEGFR2, FGFR1, and Src with various IC50s.
- Reduces the viability, migration, and function of human endothelial cells.
- Decreased cell viability in HUVEC cells in a dose-dependent manner.
- Increased the percentage of annexin/PI labeled cells in HUVEC cells.
- Reduced VEGF-induced migration in HUVEC cells.
- Protects mice from lethal influenza infection by inhibiting cytokine storm.
- Treated mice had higher survival rates and reduced the infiltration of neutrophils.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.